Open research questions in Glaucoma and retinal disorders
572 gap statements mined from Glaucoma and retinal disorders papers in our 7.9M-paper local library, which holds 2,871 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Glaucoma and retinal disorders? See the ranked Medicine journals.
What the literature leaves open
There is a need to evaluate the effects of switching from fixed dorzolamide/timolol to netarsudil on ocular surface symptoms and intraocular pressure. The study aims to address this gap by assessing the impact of this switch on patient-reported symptoms and objective measures of ocular health.
Ocular Surface Symptoms, Objective Redness, and Intraocular Pressure After a Switch from Fixed Dorzolamide/Timolol to Netarsudil in Latanoprost-Treated Glaucoma and Ocular Hypertension: A Prospective Real-World Cohort Study · 2026 · DOIPrevious studies have compared IOP profiles between independent individuals, which may be influenced by inter-patient variability. There is a need to investigate the differences in IOP profiles between medically and surgically controlled eyes in the same patient. This study aims to address this gap by comparing two different eyes of the same patient.
Intraocular pressure profiles between ipsilateral surgically and contralateral medically-controlled in primary open angle glaucoma patients · 2026 · DOILimited effective and safe treatments for glaucoma, particularly for advanced cases. Need for alternative therapeutic approaches to reduce intraocular pressure and slow disease progression.
Safety and efficacy of micropulse transscleral laser therapy for glaucoma: a two-year follow-up · 2026 · DOIThe disease has a significant impact on patients' mental health and quality of life. The paper highlights the need for a more comprehensive approach that addresses the biopsychosocial aspects of the disease.
Limited evidence comparing mydriasis-induced IOP changes across cataract, pseudophakic, and young adult eyes. The need to investigate the effect of pharmacological mydriasis on intraocular pressure across different phakic statuses and age groups.
Pharmacological Impact of Mydriatic Drops on Intraocular Pressure: Variations across Different Phakic Status and Demographic Groups · 2026 · DOIThe need to develop a standardized examination protocol to assess periocular findings.
Periocular morphology during long-term topical ophthalmic treatment: associations with prostaglandin analogs, preservatives, and eyelid manipulation · 2026 · DOIThe study is a cross-sectional study, which may not capture the full range of treatment-related periocular findings. The study's sample size is limited to 165 participants. The study did not measure the magnitude, duration, direction, and frequency of eyelid contact during each instillation.
Periocular morphology during long-term topical ophthalmic treatment: associations with prostaglandin analogs, preservatives, and eyelid manipulation · 2026 · DOIThe cross-correlation method has limitations, such as requiring a large dataset. The need for a rapid and accurate method for assessing glaucoma. The challenge of developing a method that can compensate for confounding variables.
Current methods for assessing glaucoma are time-consuming. There is a need for a rapid and accurate method for assessing glaucoma. The diagnostic power of rapid objectiveFIELD Analyser tests has not been fully evaluated.
The extraction of irregular pupil boundaries can result in poor fitting of the ellipse using the conventional method. The presence of Pulchin spots, eyelashes, and gaze direction can affect the extraction of the pupil boundary. The need for accurate and consistent data collection in natural activities, rather than controlled settings.
High-Accuracy Intermittent Strabismus Screening via Wearable Eye-Tracking and AI-Enhanced Ocular Feature Analysis · 2025 · DOIThe need for animal models that mimic the complex pathology of glaucoma beyond elevated IOP, - The lack of understanding of the exact mechanisms that lead to glaucoma, - The need for models that can investigate aspects of glaucoma not solely dependent on high IOP.
Current treatments for glaucoma have limitations, and there is a need for novel therapeutic options. Rho kinase inhibitors have emerged as a potential treatment option, but their efficacy and safety need to be further evaluated.
Further longitudinal studies with larger and more diverse populations are warranted to investigate additional behavioral, environmental, and clinical factors influencing IOP trajectories.
Longitudinal Modeling of Intraocular Pressure and Its Associated Factors Among Glaucoma Patients: Evidence from Jimma University Medical Center · 2026 · DOINovel associations with CCBs, CGRP monoclonal antibodies, and PCSK9 inhibitors warrant further investigation.
Epidemiology, Safety of Dilation, and Medication-Associated Risk of Acute Angle-Closure Crisis in the United States · 2026 · DOIEarly-onset angle-closure glaucoma (EOACG), defined as onset of angle-closure glaucoma (ACG) manifesting at or before 40 years of age, represents a distinct and understudied subset of angle-closure disease, with limited literature describing its clinical and demographic diversity.
Elevated intraocular pressure (IOP) is the only established modifiable risk factor of primary open-angle glaucoma (POAG), but the contribution of body mass index (BMI) to disease severity remains inconsistent across populations, and data from Sub-Saharan Africa are scarce.
Body Mass Index and Severity of Primary Open-Angle Glaucoma: A Multicenter Cross-Sectional Study in a Cameroonian Setting · 2026 · DOISystemic hypertension is a risk factor for glaucoma, a leading cause of irreversible blindness, yet the mechanistic basis connecting the 2 conditions remains elusive.
However, the mechanism underlying MYOC mutation-associated POAG is poorly understood.
Disease modeling of myocilin mutation-dependent normal tension glaucoma: human retinal ganglion cell susceptibility to unfolded protein response and mTOR signaling · 2026 · DOIFurther studies are needed to investigate the effects of mydriatic agents on IOP in different populations, - Research should be conducted to develop guidelines for the use of mydriatic agents, - Studies should be done to examine the long-term effects of mydriatic agents on IOP, - Investigations into the mechanisms underlying mydriatic agent-induced IOP changes…
Pharmacological Impact of Mydriatic Drops on Intraocular Pressure: Variations across Different Phakic Status and Demographic Groups · 2026 · DOILarge-scale implementation of the wearable eye-tracking device - Further analysis of the data pertaining to eye movement - Development of more advanced pupil extraction…
High-Accuracy Intermittent Strabismus Screening via Wearable Eye-Tracking and AI-Enhanced Ocular Feature Analysis · 2025 · DOILimited availability of results for new ROCK inhibitor ophthalmic solutions, - Some ROCK inhibitors have not yet produced available results, - Antimetabolites may result in severe side effects…
The study did not detect any influence of eye drop composition on the OSM, - Research specifically focusing on the OSM in animal models has been…
Examining changes in the microbiome pre-and post-glaucoma induction using animal models, - Determining whether changes in the microbiome are a direct result of glaucoma or secondary to treatments involving preservative-laden eye…
These findings support further investigation of gaze-related optic nerve traction as a potential non-IOP-related biomechanical factor in myopic NTG.
Association of Adduction-Induced Optic Nerve Head Strain with Visual Field Loss Progression in Myopic Normal-Tension Glaucoma: The Wenzhou Glaucoma Progression Study · 2026 · DOICilastatin attenuated the OHT-associated reduction in Brn3a+ RGC counts and glial activation without producing a sustained IOP-lowering effect, supporting further investigation of its potential relevance in glaucoma.
Retinal neuroinflammation and neurodegeneration in a mouse model of glaucoma: cilastatin as a protective agent in male and female mice · 2026 · DOI
Most-cited papers in Glaucoma and retinal disorders
- The Pathophysiology and Treatment of Glaucoma · JAMA · 2014 · 3,865 citations
- Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey · JAMA · 1991 · 1,264 citations
- Glaucoma · The Lancet · 2017 · 1,253 citations
- Glaucoma in Adults—Screening, Diagnosis, and Management · JAMA · 2021 · 705 citations
- Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries · Nature Communications · 2021 · 436 citations
- European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition · British Journal of Ophthalmology · 2021 · 429 citations
- Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression · Nature Genetics · 2020 · 356 citations
- THE EPIDEMIOLOGY OF OPEN-ANGLE GLAUCOMA: A REVIEW · American Journal of Epidemiology · 1983 · 330 citations
- A Population-based Evaluation of Glaucoma Screening: The Baltimore Eye Survey · American Journal of Epidemiology · 1991 · 321 citations
- Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future · Cureus · 2020 · 311 citations
Most recent work
- Primary Open-Angle Glaucoma Preferred Practice Pattern® · Ophthalmology · 2026
- Influence of Intraocular Pressure on Clinical Decision-Making in Glaucoma Management · JAMA Ophthalmology · 2026
- Primary Angle-Closure Disease Preferred Practice Pattern® · Ophthalmology · 2026
- Mitochondrial Resilience in Glaucoma: Targeting NAD+ Metabolism and Oxidative Stress in Retinal Ganglion Cell Degeneration with Nicotinamide Riboside and Berberine: Preliminary Clinical Evidence · Diseases · 2026
- Global, regional and national burden of glaucoma from 1990 to 2021 and projections to 2050: a retrospective cross-sectional study · BMJ Open · 2026
- GPX4 promotes optic nerve regeneration and retinal ganglion cell neuroprotection · Molecular Therapy · 2026
- Artificial Intelligence-Guided Endpoint Selection for Neuroprotection Trials in Glaucoma · American Journal of Ophthalmology · 2026
- An Artificial Intelligence-Based Prognostic Model for Prediction of Functional Glaucoma Progression From Clinical and Structural Data · American Journal of Ophthalmology · 2026
- Progression of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Occurs Early and Is Unassociated With Modifiable Risk Factors · American Journal of Ophthalmology · 2026
- Outcomes and Risk Factors for Failure After PRESERFLO™ MicroShunt Implantation in a Multicenter Japanese Cohort · American Journal of Ophthalmology · 2026
Find a gap in your own Glaucoma and retinal disorders sub-topic
This page shows what the Glaucoma and retinal disorders literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →